BioCryst Pharmaceuticals Appoints David W. Jenkins as Chief Scientific Officer
Position
Chief Scientific Officer
Company
BioCryst Pharmaceuticals
Description
BioCryst Pharmaceuticals has announced the appointment of David W. Jenkins to the position of Chief Scientific Officer. He will lead an efficient research team focused on external innovation for rare disease therapies.
Quick answer
BioCryst Pharmaceuticals Appoints David W. Jenkins as Chief Scientific Officer (July 15, 2026). BioCryst Pharmaceuticals is based in Durham, North Carolina, United States.
- Who is the new Chief Scientific Officer at BioCryst Pharmaceuticals?
- BioCryst Pharmaceuticals named David W. Jenkins Chief Scientific Officer, announced July 15, 2026.
- What did BioCryst Pharmaceuticals announce on July 15, 2026?
- BioCryst Pharmaceuticals has announced the appointment of David W. Jenkins to the position of Chief Scientific Officer. He will lead an efficient research team focused on external innovation for rare disease therapies.
- Where did David W. Jenkins work before joining BioCryst Pharmaceuticals?
- David W. Jenkins joins from Ipsen.
- What does BioCryst Pharmaceuticals do?
- BioCryst is focused on developing novel therapies for diseases with significant unmet needs.
- Where is BioCryst Pharmaceuticals based?
- BioCryst Pharmaceuticals is based in Durham, North Carolina, United States.
- Which similar companies made leadership changes around the same time?
- EyePoint, Inc. (July 14, 2026), Illuminare Biotechnologies (July 14, 2026), Ovid Therapeutics (July 14, 2026) and Tarsus Pharmaceuticals (July 13, 2026) also announced leadership changes within 45 days of BioCryst Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- EyePoint Appoints Tarek S. Hassan as Senior Vice President, Chief Strategic Science Officer (July 14, 2026)
- Illuminare Biotechnologies Appoints Brian Longstreet as Chief Executive Officer (July 14, 2026)
- Ovid Therapeutics Inc. Appoints Kevin Norrett as Chief Business Officer and Promotes Charles Carter to CFO (July 14, 2026)
- Tarsus Pharmaceuticals Appoints Neera Clase as Interim Chief Commercial Officer (July 13, 2026)
- Stoke Therapeutics Appoints Thomas McCauley as Chief Scientific Officer (July 13, 2026)
- Mentari Therapeutics Appoints Greg Divis as Chief Executive Officer (July 20, 2026)
Who to call at BioCryst Pharmaceuticals, and when
A new leader at BioCryst Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day BioCryst Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioCryst Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioCryst Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioCryst Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
BioCryst Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.